Cargando…
1980. Efficacy of an Oral Vancomycin Loading Dose (LD) in the Treatment of Confirmed Clostridium Difficile Infection (CDI)
BACKGROUND: Over the past decade the incidence and severity of CDI has increased significantly. The 2018 IDSA Guidelines now recommends oral vancomycin 125 mg every 6 hours as the first-line therapy for initial occurrence of CDI. However, the optimal dosage of vancomycin is not well established. Pha...
Autores principales: | Tirmizi, Samad, Jammal, Nadya, McManus, Dayna, Ruggero, Michael, Topal, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253491/ http://dx.doi.org/10.1093/ofid/ofy210.1636 |
Ejemplares similares
-
Balancing the Efficacy and Safety of Implementing a Piperacillin/tazobactam (PTZ) Antibiotic Time-out
por: Jammal, Nadya, et al.
Publicado: (2017) -
2385. Evaluating the Antibiotic Risk for Clostridioides difficile Infection (CDI): Comparing Piperacillin/Tazobactam to Cefepime and Ceftazidime
por: Rathod, Shardul, et al.
Publicado: (2019) -
SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI
por: Sattar, Abdul, et al.
Publicado: (2015) -
New advances in the treatment of Clostridium difficile infection (CDI)
por: Hedge, Dennis D, et al.
Publicado: (2008) -
729. Real World Efficacy of Bezlotoxumab for Prevention of Clostridioides Difficile Recurrence in Immunosuppressed Patients
por: Perreault, Sarah, et al.
Publicado: (2020)